Part II: Hodgkin's lymphoma—diagnosis and treatment

This publication has 43 references indexed in Scilit:

• Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study Group
  Journal of Clinical Oncology, 2003
• Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease
  Annals of Oncology, 2003
• Thoracic positron emission tomography using18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
  Blood, 2001
• 18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin’s lymphoma
  Annals of Oncology, 2001
• A Prognostic Score for Advanced Hodgkin's Disease
  New England Journal of Medicine, 1998
• 77 Combination of radiotherapy and chemotherapy is advisable in all patients with clinical stage I–II Hodgkin's disease six-year results of the EORTC-GPMC controlled clinical trials ‘H7-VF’, ‘H7-F’ and ‘H7-U’
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Hodgkin's Disease
  New England Journal of Medicine, 1993
• Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.
  Journal of Clinical Oncology, 1989
• Twenty years of MOPP therapy for Hodgkin's disease.
  Journal of Clinical Oncology, 1986
• Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's Disease
  Annals of Internal Medicine, 1986